TODOROVIC, MAJA
TODOROVIC, MAJA
Mostra
records
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.004 secondi).
Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.
2012-01-01 Mesiano G; Todorovic M; Gammaitoni L; Leuci V; Giraudo Diego L; Carnevale-Schianca F; Fagioli F; Piacibello W; Aglietta M; Sangiolo D.
Ex Vivo Allogeneic Stimulation Significantly Improves Expansion of Cytokine-Induced Killer Cells Without Increasing Their Alloreactivity Across HLA Barriers.
2012-01-01 Todorovic M; Mesiano G; Gammaitoni L; Leuci V; Giraudo Diego L; Cammarata C; Jordaney N; Carnevale-Schianca F; Gallo S; Fagioli F; Piacibello W; Elia AR; Pignochino Y; Dell'aglio C; Grignani G; Cignetti A; Aglietta M; Sangiolo D.
Transient proteasome inhibition as a strategy to enhance lentiviral transduction of hematopoietic CD34(+) cells and T lymphocytes: implications for the use of low viral doses and large-size vectors.
2011-01-01 Leuci V; Mesiano G; Gammaitoni L; Cammarata C; Capellero S; Todorovic M; Jordaney N; Circosta P; Elia A; Lesnikova M; Georges GE; Piacibello W; Fagioli F; Cignetti A; Aglietta M; Sangiolo D
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors. | 2012 | Mesiano G; Todorovic M; Gammaitoni L; Leuci V; Giraudo Diego L; Carnevale-Schianca F; Fagioli F; Piacibello W; Aglietta M; Sangiolo D. | |
| Ex Vivo Allogeneic Stimulation Significantly Improves Expansion of Cytokine-Induced Killer Cells Without Increasing Their Alloreactivity Across HLA Barriers. | 2012 | Todorovic M; Mesiano G; Gammaitoni L; Leuci V; Giraudo Diego L; Cammarata C; Jordaney N; Carnevale-Schianca F; Gallo S; Fagioli F; Piacibello W; Elia AR; Pignochino Y; Dell'aglio C; Grignani G; Cignetti A; Aglietta M; Sangiolo D. | |
| Transient proteasome inhibition as a strategy to enhance lentiviral transduction of hematopoietic CD34(+) cells and T lymphocytes: implications for the use of low viral doses and large-size vectors. | 2011 | Leuci V; Mesiano G; Gammaitoni L; Cammarata C; Capellero S; Todorovic M; Jordaney N; Circosta P; Elia A; Lesnikova M; Georges GE; Piacibello W; Fagioli F; Cignetti A; Aglietta M; Sangiolo D |